With the rise of personalized medicine, should governments prioritize funding for treatments tailored to individuals, even if they are more expensive, or focus on widely applicable public health initiatives? What are the ethical considerations?

The advent of personalized medicine, which tailors treatment to an individual’s genetic makeup, lifestyle, and environment, has revolutionized modern healthcare. However, this innovation comes with significant cost implications. While it offers immense potential for improved patient outcomes, governments face the dilemma of whether to allocate public funds towards these costly individualized treatments or to invest […]